666

HUNAN NUCIEN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪1.81 B‬CNY
‪3.75 M‬CNY
‪734.36 M‬CNY
‪233.31 M‬
Beta (1Y)
1.55

About HUNAN NUCIEN PHARMACEUTICAL

CEO
Shi Xi Zhang
Headquarters
Guangzhou
Website
Employees (FY)
360
Founded
2006
FIGI
BBG00PLJXP61
Hunan Nucien Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. It offers antibiotics, antipyretic and analgesic, and drugs for cardiovascular and cerebrovascular diseases in the form of injections, tablets and capsules. The company was founded on December 27, 2006 and is headquartered in Guangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 688189 is 6.84 CNY — it has increased by 1.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HUNAN NUCIEN PHARMACEUTICAL stocks are traded under the ticker 688189.
688189 stock is 3.12% volatile and has beta coefficient of 1.55. Check out the list of the most volatile stocks — is HUNAN NUCIEN PHARMACEUTICAL there?
Yes, you can track HUNAN NUCIEN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
688189 stock has risen by 3.95% compared to the previous week, the month change is a 8.43% fall, over the last year HUNAN NUCIEN PHARMACEUTICAL has showed a 26.79% decrease.
688189 net income for the last quarter is ‪3.10 M‬ CNY, while the quarter before that showed ‪−27.76 M‬ CNY of net income which accounts for 111.17% change. Track more HUNAN NUCIEN PHARMACEUTICAL financial stats to get the full picture.
Today HUNAN NUCIEN PHARMACEUTICAL has the market capitalization of ‪1.81 B‬, it has increased by 6.29% over the last week.
Like other stocks, 688189 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUNAN NUCIEN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
688189 reached its all-time high on Aug 13, 2020 with the price of 42.68 CNY, and its all-time low was 5.41 CNY and was reached on Feb 6, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 360.00 employees. See our rating of the largest employees — is HUNAN NUCIEN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUNAN NUCIEN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUNAN NUCIEN PHARMACEUTICAL stock shows the sell signal. See more of HUNAN NUCIEN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUNAN NUCIEN PHARMACEUTICAL EBITDA is ‪58.66 M‬ CNY, and current EBITDA margin is 7.99%. See more stats in HUNAN NUCIEN PHARMACEUTICAL financial statements.